Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing by unknown
RESEARCH ARTICLE Open Access
Genome-wide analyses of long noncoding
RNA expression profiles correlated with
radioresistance in nasopharyngeal
carcinoma via next-generation deep
sequencing
Guo Li1,2, Yong Liu1,2, Chao Liu1,2, Zhongwu Su1,2, Shuling Ren1,2, Yunyun Wang1,2, Tengbo Deng1,2,
Donghai Huang1,2, Yongquan Tian1,2 and Yuanzheng Qiu1,2*
Abstract
Background: Radioresistance is one of the major factors limiting the therapeutic efficacy and prognosis of patients
with nasopharyngeal carcinoma (NPC). Accumulating evidence has suggested that aberrant expression of long
noncoding RNAs (lncRNAs) contributes to cancer progression. Therefore, here we identified lncRNAs associated with
radioresistance in NPC.
Methods: The differential expression profiles of lncRNAs associated with NPC radioresistance were constructed by
next-generation deep sequencing by comparing radioresistant NPC cells with their parental cells. LncRNA-related
mRNAs were predicted and analyzed using bioinformatics algorithms compared with the mRNA profiles related to
radioresistance obtained in our previous study. Several lncRNAs and associated mRNAs were validated in
established NPC radioresistant cell models and NPC tissues.
Results: By comparison between radioresistant CNE-2-Rs and parental CNE-2 cells by next-generation deep
sequencing, a total of 781 known lncRNAs and 2054 novel lncRNAs were annotated. The top five upregulated and
downregulated known/novel lncRNAs were detected using quantitative real-time reverse transcription-polymerase
chain reaction, and 7/10 known lncRNAs and 3/10 novel lncRNAs were demonstrated to have significant differential
expression trends that were the same as those predicted by deep sequencing. From the prediction process, 13
pairs of lncRNAs and their associated genes were acquired, and the prediction trends of three pairs were validated
in both radioresistant CNE-2-Rs and 6-10B-Rs cell lines, including lncRNA n373932 and SLITRK5, n409627 and PRSS12,
and n386034 and RIMKLB. LncRNA n373932 and its related SLITRK5 showed dramatic expression changes in
post-irradiation radioresistant cells and a negative expression correlation in NPC tissues (R = −0.595, p < 0.05).
Conclusions: Our study provides an overview of the expression profiles of radioresistant lncRNAs and potentially
related mRNAs, which will facilitate future investigations into the function of lncRNAs in NPC radioresistance.
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Background
Radiotherapy is the mainstay treatment for patients with
nasopharyngeal carcinoma (NPC). Despite major advances
in radiation techniques and radiotherapeutic strategies,
the prognosis and survival rates of patients with NPC
remain unsatisfactory [1, 2]. One of the major factors con-
tributing to the poor outcomes in NPC is the occurrence of
radioresistance, and therefore radioresistance is a hot topic
in both basic and clinical research. Multiple studies have
shown that radioresistance-associated molecules (mRNAs,
microRNAs, and proteins) influence radioresistance by
regulating radioresistance-associated processes, including
DNA repair capacity, apoptosis, cell cycle arrest, and pro-
tective autophagy [3–5]. Previous studies have improved
our understanding of radioresistance. However, the exact
molecular mechanisms underlying radioresistance remain
unclear.
Approximately 1.5 % of the entire human genome is
involved in protein transcription and translation [6]. The
majority of the remaining noncoding regulatory ele-
ments are transcribed into noncoding RNAs that have
been implicated in a variety of human diseases including
cancers. Long noncoding RNAs (lncRNAs) are a novel
class of mRNA-like transcripts that have been shown to
be involved in the development and progression of dif-
ferent cancers [7]. Moreover, studies analyzing large clin-
ical cancer samples have demonstrated that certain
lncRNAs (i.e., HOTAIR and MALAT1) serve as valuable
prognostic biomarkers [8, 9]. Therefore, increasing stud-
ies have focused on the functions and mechanisms of
lncRNAs in cancer malignant behaviors such as unlim-
ited proliferation, migration, and metastasis [10, 11].
However, few investigations have focused on the associ-
ation of lncRNAs with cancer radioresistance.
In an effort to improve our understanding of the mecha-
nisms of radioresistance, we previously established NPC
radioresistant cell lines by gradually increasing the dose of
irradiation [11, 12]. Based on the potential roles proposed
for lncRNAs in cancer-related behaviors, here we inves-
tigated the possible lncRNAs mediating NPC radioresis-
tance. We compared NPC radioresistant cells and parental
cells to obtain global lncRNA expression profiles asso-
ciated with radioresistance using next-generation, high-
throughput deep sequencing technology.
Methods
Cell lines and cell culture
The CNE-2 and 6-10B poorly differentiated NPC cell
lines were purchased from the Cell Center of Central
South University (Changsha, China). CNE-2-Rs and 6-
10B-Rs cells, which exhibit a radioresistant phenotype,
were established through exposure to gradually increasing
levels of irradiation as previously described [12, 13]. All
cells were propagated in RPMI 1640 medium (Hyclone,
Logan, UT, USA) with 10 % fetal bovine serum (Gibco
BRL, Gaithersburg, MD, USA) and 1 % antibiotics (Gibco
BRL) and incubated at 37 °C with saturated humidity and
5 % CO2.
Patient tissues
Forty-three NPC tissues were obtained from patients
undergoing biopsy of the nasopharynx at the Department
of Otolaryngology Head and Neck Surgery, Xiangya Hos-
pital, Central South University from March 2014 to March
2015. All NPC patients had no history of radiotherapy or
chemotherapy. All tissues were immediately snap frozen
and stored in liquid nitrogen before total RNA extraction.
Informed consent was obtained from all patients prior
to the biopsy. The study was approved by the Research
Ethics Committee of Central South University, Changsha,
China.
RNA extraction
Total RNA was extracted from NPC cells using TRIzol
(Invitrogen, Carlsbad, CA, USA) according to the manu-
facturer’s protocol. Total RNA from the NPC radioresis-
tant cell line CNE-2-Rs and its parental cell line CNE-2
was analyzed using the Agilent RNA 6000 Nano LabChip®
kit with the Agilent 2100 Bioanalyser (Agilent Technolo-
gies, Palo Alto, CA, USA) to determine its quantity and
integrity. According to criteria in the literature, only sam-
ples that scored more than 4 were considered to be reli-
able samples for the next sequencing step [14].
The RNA of other cells (i.e., 6-10B, 6-10B-Rs, NPC
cells with or without irradiation) and NPC tissues were
also extracted for the sequencing result validation. The
concentration and integrity of the RNAs were deter-
mined using a Nano Drop 2000 Spectrophotometer
(Thermo Scientific, Wilmington, DE, USA). RNA quality
was determined by quantification of 28S and 18S riboso-
mal RNA on ethidium bromide (EB)-stained gels.
Construction of a RNA library for sequencing
RNA was extracted from CNE-2 and CNE-2-Rs cells,
and the Ribo-Zero™ Kit (Epicentre, Madison, WI, USA)
was used to remove the rRNA. The remaining RNA was
cut randomly into short fragments. First-strand cDNA
was transcribed based on these random fragments using
random hexamers; second-strand cDNA was transcribed
by mixing the first-strand cDNA with buffer, dNTPs, RNase
H, and DNA polymerase I. Short fragments were purified
using the QIAquick PCR Purification Kit (Qiagen, Valencia,
CA, USA) and resolved with EB buffer for end reparation
and single nucleotide A (adenine) addition. The short frag-
ments were connected with adapters and the second strand
was degraded using UNG (uracil-N-glycosylase). RNA
fragments were separated by agarose gel electrophoresis,
and the fragments were expanded with polymerase chain
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reaction (PCR). The PCR products were sequenced using
an Illumina HiSeq™ 2000 instrument (Illumina Inc., San
Diego, CA, USA), and the original image data were con-
verted into “.fq” files by base calling software. The relative
data were submitted to NCBI under BioProject accession
No. PRJNA 254709. The details of the experiment were as
follows: expected library size: 200 bp; read length: 90 nt;
and sequencing strategy: paired-end sequencing.
Raw data filtering and rRNA removal
The raw reads were saved in the fastq format. We re-
moved the dirty raw reads prior to data analysis. Three
criteria were used to filter out dirty raw reads: 1) reads
with adapters were removed; 2) reads in which unknown
bases occurred with a frequency greater than 10 % were
removed; and 3) low-quality reads (the percentage of
low-quality bases was over 50 % in a read). Filtered reads
were removed. The remaining reads were called “clean
reads” and used for the bioinformatics analyses.
In consideration of rRNA pollution interference in
the analysis, the clean reads were mapped to an rRNA
reference sequence using the short reads alignment soft-
ware SOAP2 (http://soap.genomics.org.cn/) to remove the
remaining rRNA reads. The remaining reads were used
for transcriptome assembly and quantification.
Transcript reconstruction
The removed rRNA reads were mapped to a reference
genome using an improved version of TopHat2 (http://
ccb.jhu.edu/software/tophat/index.shtml) that could align
reads across splice junctions without relying on gene
annotation. We permitted two base pair mismatches in
this step. Reads mapped to the genome were assembled
by Cufflinks [15]. We used the Reference Annotation
Based Transcripts algorithm to assemble the reads into
transcripts.
Known and unknown lncRNA identification
The transcripts were BLASTed against the NONCODE
v3.0 database (http://www.noncode.org/NONCODERv3/)
to identify known noncoding RNAs using the following
selection criteria: identity > 0.9, coverage > 0.8, and E-value
< 105. These transcripts were named as the ID number in
the NONCODE v3.0 database.
Transcripts without annotations in the ncRNA library
were compared with protein databases such as the KEGG
(Kyoto Encyclopedia of Genes and Genomes), nr (non-
redundant amino acid database), COG (Cluster of ortho-
logous Groups of proteins), and Swissprot Database, and
the mapped transcripts were considered to be mRNA
(identity > 0.9 and coverage > 0.8). The remaining tran-
scripts that were not aligned with the protein library were
inputted into the Coding Potential Calculator program
to distinguish coding and noncoding sequences. A true
protein-coding transcript is more likely to have a long and
high-quality open reading frame (ORF) compared with a
non-coding transcript. Here, we considered the following
six features: log-odds score, coverage of the predicted
ORF, integrity of the predicted ORF, number of HITs, hit
score, and frame score (http://cpc.cbi.pku.edu.cn/).
Establishment of differential expression profiles
To obtain the differential expression profiles, read counts
and reads per kilobase per million reads (RPKM) values





in which C was the number of reads that uniquely
mapped to the given lncRNAs, N was the number of
reads that uniquely mapped to all lncRNAs, and L was
the total length of the lncRNA. For lncRNAs with more
than one alternative transcript, the longest transcript
was selected to calculate the RPKM. The RPKM method
eliminates the influence of different lncRNA lengths
and sequencing discrepancies on the lncRNA expression
calculation. Therefore, the RPKM value can be directly used
to compare differences in lncRNA expression among sam-
ples. Then, we identified differentially expressed lncRNAs
between the radioresisitant NPC cell CNE-2-Rs and the
radiosensitive parental cell CNE-2 based on the following
criteria: false discovery rate ≤ 0.001 and fold change ≥ 2.
NPC radioresistant mRNA differential expression profiles
were reported in our previous study [11]. LncRNAs and
mRNAs with differential expression were selected for the
subsequent analyses.
Prediction of mRNA-related lncRNAs
At present, there are no widely accepted standardized
algorithms for the prediction of mRNAs potentially associ-
ated with lncRNAs. In current publications, the prediction
strategies are primarily based on the mutual interaction
between lncRNAs and their associated mRNAs; antisense
and up/downstream prediction methods are two common
strategies for the prediction of lncRNA-related mRNAs.
To examine antisense lncRNA-mRNA interactions, we
searched all antisense lncRNA-mRNA duplexes with com-
plementary base pairing using the RNAplex software with
the ViennaRNA package [16, 17]. The antisense lncRNA
and its target mRNA were selected according to the mini-
mum free energy, complementary base coverage (>95 %),
and opposing expression trends. Up/downstream lncRNA
candidates were predicted by a BLAST search of lncRNA
sequences in the flanking regions of the coding genes. We
defined the flanking region as the sequence within 2 kb
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up- or downstream of the coding genes in which most of
the regulatory elements were located.
Real-time quantitative reverse transcription-PCR (qRT-PCR)
validation of differentially expressed lncRNAs
Briefly, cDNA was transcribed from total RNA using the
PrimeScript RT reagent kit with a DNA Eraser (TaKaRa,
Shiga, Japan). Primers for lncRNAs were designed and
synthesized. Then, qPCR assays were performed using
a Bio-Rad IQTM5 Multicolor Real-Time qRT-PCR de-
tection system (Bio-Rad, Hercules, CA, USA). The ex-
pression levels of lncRNAs and genes were detected
using primers specific for the lncRNAs and mRNAs
(Additional file 1: Table S1). Human beta-actin was used
as a housekeeping gene for normalization. The expression
levels of lncRNAs and mRNAs were measured in terms of
the cycle threshold (CT) and normalized to beta-actin
expression using the 2-ΔΔCt method.
Irradiation
Irradiation was delivered at room temperature with a
6-MeV electron beam generated by the linear accelerator
2100EX (Varian Medical, Inc., Palo Alto, CA, USA) at a
dose rate of 300 cGy/min. A compensation glue with
1.5-cm thickness covered the cell culture containers. The
source-to-skin distance was 100 cm.
Statistical analysis
The results of the quantitative data in this study were
expressed as the mean ± standard deviation. The statistical
significance of the differences between two groups was
analyzed using a two-sided unpaired Student’s t test (for
equal variance) or Welch’s corrected t test (unequal vari-
ance). The correlation between lncRNA n373932 and
SLITRK5 mRNA expressions was first made as a napierian
logarithmic transformation (base number is approximately
2.7183) and then calculated using bivariate correlation
analyses (Pearson correlation). The above analyses were
performed with SPSS 18.0 software (IBM Corporation,
Armonk, NY, USA). Differences with P values less than
0.05 were considered statistically significant.
Results
Construction of lncRNA profiles that correlated with NPC
radioresistance
To obtain lncRNA expression profiles associated with
radioresistance, we constructed cDNA libraries using our
previously established radioresistant CNE-2-Rs and paren-
tal CNE-2 cell lines [11]. As depicted in Fig. 1, a total of
65,688,822 and 63,933,890 clean reads were obtained from
the CNE-2-Rs and CNE-2 cells, respectively. After elimi-
nating reads mapped to rRNA, TopHat2 and Cufflinks
were used to reconstruct transcripts in both samples.
The reconstructed transcripts were BLASTed against the
NONCODE v3.0 database. A total of 11,094 transcripts in
the CNE-2-Rs cells and 9,635 transcripts in the CNE-2 cells
were annotated as known lncRNAs. Following elimination
of transcripts mapped to mRNA and coding sequences,
8,380 (CNE-2-Rs) and 8,511 (CNE-2) transcripts were
separately identified as novel lncRNAs. The unique mapped
reads for each lncRNA were counted, and the RPKM values
for each lncRNA were calculated. Based on the criteria
of an absolute fold change > 2.0 and a false discovery rate
< 0.001, 781 known lncRNAs and 2,054 novel lncRNA can-
didates were finally obtained. These lncRNAs constituted
the differential lncRNA expression profiles associated with
NPC radioresistance (Additional file 2: Table S2).
Overview of the lncRNAs associated with NPC
radioresistance
The features of the lncRNAs were analyzed based on the
above-mentioned lncRNA profiles. Our data revealed that
most known lncRNAs were 200 bp to 3 kb in length
(Fig. 2a), while the novel candidates were mainly distri-
buted between 200 bp and 2 kb (Fig. 3a). Among the 781
known lncRNAs, 715 lncRNAs were expressed in both
cell lines and 31 and 35 were present only in CNE-2-Rs or
CNE-2 cells, respectively (Fig. 2b). A total of 310 lncRNAs
were upregulated and 471 lncRNAs were downregulated
in the radioresistant CNE-2-Rs cells compared with the
parental CNE-2 cells (Fig. 2c). Similarly, 1800 lncRNAs of
the 2054 lncRNA candidates were expressed in both cells,
while 192 and 62 were expressed only in CNE-2-Rs or
CNE-2, respectively (Fig. 3b). A total of 406 lncRNAs were
elevated and 1648 were decreased in the radioresistant
CNE-2-Rs cells (Fig. 3c).
To confirm the consistency of the known and novel
lncRNA expression profiles, the top five upregulated and
downregulated lncRNAs in both the known and novel
lncRNAs were identified. Our qRT-PCR assays verified
that 7 of 10 known lncRNAs exhibited a significant diffe-
rential expression with the same trend observed in the
deep sequencing prediction, including the upregulated
lncRNAs n333177, n689, and n375997 and the downregu-
lated lncRNAs n376834, n381831, n370764, and n341810
(Fig. 2d). A total of 3 of 10 novel candidates displayed
the same expression changes as the prediction, including
Unigene3434, Unigene8485, and Unigene8588 (Fig. 3d).
Our results indicated that the known lncRNAs had a
higher matching ratio than the novel lncRNAs. We mainly
focused on these known candidates in this study.
Prediction of lncRNA and mRNA associations based on
the antisense and up/downstream strategies
At present, there are no widely accepted standardized
algorithms for the prediction of the potential association
of mRNAs with lncRNAs. In current publications, the
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prediction strategies are primarily based on the mutual
interaction method between lncRNAs and their asso-
ciated mRNAs; the antisense and up/downstream predic-
tion methods are two common strategies for the prediction
of lncRNA and mRNA associations [18, 19]. Therefore,
based on the radioresistant lncRNA profiles and mRNA
profiles established in our previous work, we initially used
the antisense prediction method to search all antisense
lncRNA-mRNA duplexes via the RNAplex software. This
program searches for complementary pairing between the
bases of the lncRNAs and potential mRNAs. Two lncRNAs
(n342800 and n341092) were found to be complementarily
paired with the mRNAs NFE2 L3 and CHORDC1 (Table 1).
The up/downstream prediction strategy was also used to
BLAST the lncRNA sequences within the 2 kb upstream
or downstream regions of the mRNA coding sequences.
As shown in Table 1, 7 lncRNAs (n373932, n411012, n37
6260, n339364, n369600, n345672, and n367357) were
found to bind to the upstream region of their associated
mRNAs (SLITRK5, MNX1, RAB3A, TWF2, PDK4, H1FX,
and CCNG2), and four lncRNAs (n409627, n386034, n410
131, and n386687) were predicted to interact with the
downstream domain of their potential mRNAs (PRSS12,
RIMKLB, ZNF783, and NEU3). Taken together, the base-
pairing prediction strategy provided 13 pairs of lncRNAs
and associated mRNAs that served as clues to investigate
their actual interactions and affections on NPC radioresis
tance.
Validation of the lncRNAs and their related mRNAs by
qRT-PCR
Based on the above prediction results, we evaluated these
13 pairs of lncRNAs and their associated mRNAs by qRT-
PCR. To increase the credibility of our validation assays, we
also included previously constructed radioresistant NPC
6-10B-Rs cells [11]. Our validation assays demonstrated
that three pairs of lncRNAs and their associated genes
exhibited changes that corresponded to the prediction in
both radioresistant cell lines, including lncRNA n373932
and SLITRK5, n409627 and PRSS12, and n386034 and RI
MKLB. Among the remaining 10 pairs, four lncRNAs (n3
42800, n345672, n386687, and n410131) exhibited altered
expression in both radioresistant cells that corresponded
to the sequencing results, but their associated genes did
not correspond to the sequencing; the expression levels of
the last six pairs were inconsistent with the predictions in
both the lncRNAs and genes (Fig. 4a, b).
For better understanding the molecular reaction of
NPC cells to irradiation, CNE-2-Rs, 6-10B-Rs, and their
parental cells were exposed to 4Gy irradiation. We chose
three pairs of lncRNAs and their associated genes (n373932
and SLITRK5, n409627 and PRSS12, and n386034 and
Fig. 1 The work flow of constructing long noncoding RNA profiles correlated with NPC radioresistance
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RIMKLB) for study in CNE-2-Rs and CNE-2. We found
that lncRNA n373932 and n386034 showed dramatic
expression changes in post-irradiation cells, especially in
radioresistant cells. n409627 also had a post-irradiation
increase but did not decrease as its sequencing result.
(Fig. 5a). Among the targeted genes, only SLITRK5 and
PRSS12 showed dramatically increase with irradiation
exposure, and RIMKLB changed slightly. Then, we found
similar trends with n373932 and SLITRK5 in 6-10B-Rs
and 6-10B cells (Fig. 5b). Thus, we detected n373932 and
Fig. 2 Overview of known lncRNAs associated with NPC radioresistance. a The length distributions of the transcripts. b The known lncRNAs
identified in CNE-2 and CNE-2-Rs cells. The shaded area represented the lncRNAs found in both samples, and the areas coloured red and blue showed
the number of lncRNAs expressed in samples CNE-2 and CNE-2-Rs, respectively. c Scatter plot of lncRNA expression profiles in radiosensitive CNE-2
(x-axis) and radioresistant CNE-2-Rs cells (y-axis). The significantly up-regulated lncRNAs were marked in red and the down-regulated lncRNAs
in blue. |log2 Fold change| ≥ 1 and FDR < 0.001. d Validation of the expression levels of the top five up-regulated and down-regulated
known lncRNAs via qRT-PCR
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Fig. 3 Overview of novel lncRNA candidates associated with NPC radioresistance. a The length distributions of the transcripts. b The novel
transcripts identified in CNE-2 and CNE-2-Rs cells. The shaded areas represented the lncRNAs found in both samples, and the areas coloured red
and blue showed the number of lncRNAs expressed in samples CNE-2 and CNE-2-Rs, respectively. c Scatter plot of lncRNA expression profiles in
radiosensitive CNE-2 (x-axis) and radioresistant CNE-2-Rs cells (y-axis). The significantly up-regulated novel lncRNAs were marked in red and the
down-regulated lncRNAs in blue. |log2 Fold change|≥ 1 and FDR < 0.001. d Validation of the expression of the top five up-regulated and
down-regulated novel transcripts via qRT-PCR
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SLITRK5 in 43 NPC tissues via qRT-PCR analysis. The re-
sults showed that the expressions of n373932 and SLITRK5
were negatively correlated (R = −0.595, p < 0.001) (Fig. 5c).
The interactions and functions should be investigated in
future studies.
Discussion
Intrinsic and acquired radioresistance is a major chal-
lenge in the management of patients with NPC [12, 20].
In routine clinical practice, NPC tissues that exhibit
radioresistance are hard to obtain because remaining
NPC tissues are scarce after a full course of radiotherapy
and surgery is not the first-line therapeutic choice for
patients with NPC. Hence, the established radioresistant
NPC cell model is the best option to study the potential
role of lncRNAs in NPC radioresistance. In this study,
we generated global lncRNA expression profiles asso-
ciated with NPC radioresistance using next-generation
deep sequencing (NGS). Using this approach, we obtained
known lncRNAs and novel lncRNA candidates for further
investigations into the function and mechanism of NPC
radioresistance.
Table 1 Antisense lncRNA and up/downstream-associated
lncRNA prediction
lncRNA Fold change Gene name Fold change Origin
n342800 −2.21 NFE2L3 2.49 Anti-sense
n341092 2.29 CHORDC1 −1.31 Anti-sense
n409627 −2.07 PRSS12 9.93 Down-stream
n386034 −1.92 RIMKLB −1.26 Down-stream
n410131 −1.71 ZNF783 −1.28 Down-stream
n386687 1.04 NEU3 1.08 Down-stream
n373932 −10.59 SLITRK5 1.93 Up-stream
n411012 1.37 MNX1 2.55 Up-stream
n376260 1.74 RAB3A 3.09 Up-stream
n339364 2.19 TWF2 1.16 Up-stream
n369600 2.52 PDK4 −1.89 Up-stream
n345672 3.52 H1FX 1.55 Up-stream
n367357 9.64 CCNG2 2.07 Up-stream
Fig. 4 Validation of the lncRNAs and associated genes by qRT-PCR. Three pairs of lncRNAs and their associated genes exhibited corresponding
changes in the prediction and both radioresistant cell lines, including lncRNA n373932 and SLITRK5, n409627 and PRSS12, and n386034
and RIMKLB
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Conventional RNomic research has relied on microarray
platforms. With the innovations in RNA-sequencing tech-
nologies and computational biology, NGS emerged and has
been widely applied in RNomics research. In our lncRNA
study, NGS not only allowed massive parallel analyses of
genome-wide expression using microarrays but also had
the advantages of calculating the absolute abundance of
the transcripts, identifying variations in lncRNA sequences
and discovering novel lncRNAs. Accordingly, in addition to
781 known lncRNAs, we obtained 2054 novel aberrantly
expressed lncRNAs that were associated with NPC radiore-
sistance. These lncRNAs might greatly enrich the human
lncRNA pool.
Recent findings have implicated lncRNAs in the pro-
cesses of cancer development and progression. Their aber-
rant expression confers cancer cells with the capacity for
malignant transformation, growth, metastasis, and resis-
tance to chemoagents [21]. However, few reports have
investigated the role of lncRNAs in radioresistance, with
the exception of the following three publications. Wang et
al. found that LincRNA-p21 enhanced colorectal cancer
radiosensitivity by affecting the WNT signaling pathway
[22]. LncRNA BOKAS decreased the radioresistance of
esophageal squamous cell carcinoma via targeting WISP1
[23]. Reversed expression of AK94004 in NPC improved
curcumin-induced irradiation damage [24]. In our current
study, 781 known lncRNAs related to NPC radioresistance
were obtained, few of which have been studied systematic-
ally and comprehensively.
To obtain a better understanding of the function of
lncRNAs in cancer, it is important to predict and inves-
tigate the possible genes that may be regulated by lncRNAs.
In most cases, researchers analyzed the expression correla-
tions between lncRNAs and mRNAs/proteins in multiple
samples (three or more samples) [25, 26]. Notably, this
type of analysis emphasizes the linear correlation between
lncRNAs and their associated genes and neglects the
important biases caused by the complicated regulation
mechanisms of lncRNAs on their potential regulatory
mRNAs/proteins. Our data were obtained from two cell
samples (a radioresistant cell line and its parental cell line)
and were insufficient for expression correlations based on
statistical analysis. Thus, we adopted two prediction stra-
tegies from the bioinformatics perspective: the antisense
and the up/downstream methods. The antisense lncRNA
prediction algorithm depended on the hypothesis that
lncRNA transcripts were transcribed from the strand
opposite that of the sense transcript of the protein-coding
sequence, and consequently resulted in transcriptional and
post-transcriptional suppression via a series mechanism
(i.e., RNA polymerase collisions, difficulties in mRNA splice
site recognition, and lncRNA-mRNA combinations) [27].
Upstream lncRNAs are defined as transcripts derived
within 2 kb upstream from the transcription start sites.
The 2-kb upstream region possesses a frequent distri-
bution of human gene promoters [28]. Therefore, these
lncRNAs may affect their target mRNAs at the transcrip-
tional level by interacting with the promoter region of spe-
cial mRNAs [26]. Theoretically, these lncRNAs might also
inhibit or promote target mRNAs via other cis-regulated
elements, such as enhancers and silencers that may
located within this 2-kb upstream region, which need
further validation. Our results also demonstrated that four
pairs of lncRNAs and mRNAs were predicted to interact
in the 2-kb downstream region by possible binding based
on complementary base sequences between the lncRNAs
and the mRNA transcriptional domains. However, regula-
tion from the downstream region has not been previously
reported.
Our final validation assays demonstrated that three pairs
of lncRNAs and their related genes exhibited changes in
radioresistant cells that corresponded to the predictions,
including lncRNA n373932 and SLITRK5, n409627 and
PRSS12, and n386034 and RIMKLB. To the best of our
knowledge, no studies have linked the three validated lnc
RNAs (n373932, n409627, and n386034) to biological and
pathological processes of human diseases. With respect to
their related mRNAs, SLITRK5 was shown to be expressed
in leukemia, embryonic stem cells, subsets of endothelial
cells, and neural tissues, and its dysfunction could impair
corticostriatal circuitry and lead to obsessive-compulsive-
like behaviors [29]. PRSS12 (Motopsin) is a mosaic protease
Fig. 5 Detection of the lncRNAs and associated genes by qRT-PCR in irradiated cells and NPC cells. a, b lncRNA n373932 and SLITRK5 had dramatic
mRNA expression change in post-irradiation cell, expecially in radioresistant cells. c After making napierian logarithmic transformation and Bivariate
Correlation analyses, we found that n373932 and SLITRK5 had a negative exprssion correlation (R = −0.595, p < 0.001, Fig. 5c)
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expressed in the central nervous system; truncation of the
human motopsin gene causes nonsyndromic mental retar-
dation [30]. RIMKLB is expressed at the highest level in the
testis and is involved in the synthesis of β-citrylglutamate,
which may play a critical role in spermatogenesis [31]. No
studies have examined these lncRNAs and mRNAs in
terms of cancer malignant behaviors including radioresis-
tance, and their interactions and functions still need to be
investigated and validated. In addition to the prediction
strategies used in our study, other prediction strategies have
been used to analyze mRNAs associated with lncRNAs
[7, 18]. In fact, lncRNA also formed with thousands bases
and thus has a complex secondary and tertiary structure
[32]. The complicated structure of lncRNAs allows binding
to proteins, RNAs, and/or DNA partners and thus partici-
pation in multiple regulatory mechanisms. These theories
can also give prompts for our next of NPC radioresistance
study.
Conclusion
Radioresistance is always a in crucial factor limiting the
therapeutic efficacy and prognosis of NPC patients. Here
we constructed an expression profile of lncRNAs in human
NPC cells and found a distinct lncRNA expression profile
in radioresistant cells, suggesting that these unique non-
coding transcripts might contribute to the acquisition of
radioresistance in NPC. Although additional in vivo stu-
dies and clinical trials are needed to verify the lncRNAs
mentioned above, our study provides important insights
into novel potential treatment strategies or prognostic
indicators for patients with NPC.
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